Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling

Berberine acts as a natural inhibitor of Wnt/β-catenin signaling-Identification of more active 13-arylalkyl derivatives

(2013) Kai Frederik Albring et al.   BIOFACTORS

Antitumor effect of novel berberine derivatives in breast cancer cells

(2013) Elisa Pierpaoli et al.   BIOFACTORS

The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer

(2013) Yan Ni Loh et al.   BMC CANCER

Receptor Tyrosine Kinase-like Orphan Receptor 2 (Ror2) Expression Creates a Poised State of Wnt Signaling in Renal Cancer

(2013) Neal R. Rasmussen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Berberine: New perspectives for old remedies

(2012) Micol Tillhon et al.   BIOCHEMICAL PHARMACOLOGY

The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis

(2012) Caroline E. Ford et al.   INTERNATIONAL JOURNAL OF CANCER

Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance

(2011) Rabab A A Mohammed et al.   MODERN PATHOLOGY

Missing covariate data in medical research: To impute is better than to ignore

(2010) Kristel J.M. Janssen et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Poor-Prognosis Estrogen Receptor-Positive Breast Cancer Identified by Histopathologic Subclassification

(2008) L. R. Webster et al.   CLINICAL CANCER RESEARCH